ERDERA Clinical Trial Call 2026 – Information Webinar
July 6, 2026 | 3:00–5:00 PM
ERDERA will launch its Clinical Trial Call 2026 (ECTC) on 1 July 2026, supporting multinational, GCP‑compliant early‑phase interventional clinical trials in rare diseases.
To provide further information and guidance on the call, ERDERA will host an informational webinar on 6 July 2026, from 15:00 to 17:00. During this session, participants will have the opportunity to hear directly from ERDERA experts, who will present the objectives, scope, and requirements of the call, and address questions from prospective applicants.
An information webinar will provide an overview of the call objectives, eligibility requirements, evaluation process and indicative timeline.
More information and registration here.
Funding Mechanism
all funding is provided centrally from the European Commission contribution to ERDERA and is administered and distributed by Fondazione Telethon (FTELE). Up to €30 million of the ERDERA budget is available to fund projects under this call. The requested budget for each project should be adequate for the needs of the proposed work. Budgets are expected to be in the range of €1 million to €5 million per project.
More information about the upcoming call and webinar is available at the following links:
https://erdera.org/call/ctc2026
https://erdera.org/news/erdera-clinical-trial-call-2026-pre-announcement-and-key-dates
ERDERA Clinical Trial Call 2026 – Information Webinar – ERDERA
For scientific queries, contact the Clinical Trial Call Scientific Secretariat:
CONTACT PERSON
Katarína Bibová
T: 02/ 57510 136